Krka Polska to Sell Monkasta in Poland Again
Novo Mesto/Warsaw, 5 May - The Warsaw Higher Court has lifted a ban on the production and sale of a drug containing the active ingredient montelukast for a Polish subsidiary of the Slovenian pharma Krka.
The rest of this news item is available to subscribers.
The news item consists of 679 characters (without spaces) or 132 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.